It is a lovely spring day in Sydney - far away from the horrors of the world!
David.
Monday 10am - Issues seem to be resolved!
D.
This blog is totally independent, unpaid and has only three major objectives.
The first is to inform readers of news and happenings in the e-Health domain, both here in Australia and world-wide.
The second is to provide commentary on e-Health in Australia and to foster improvement where I can.
The third is to encourage discussion of the matters raised in the blog so hopefully readers can get a balanced view of what is really happening and what successes are being achieved.
It is a lovely spring day in Sydney - far away from the horrors of the world!
David.
Monday 10am - Issues seem to be resolved!
D.
Spotted this this week:
As the tool becomes less of a curiosity and more a part of daily life, fans are finding clever uses – and discovering limitations
First published on Fri 13 Oct 2023 00.00 AEDT
Next month ChatGPT will celebrate its first birthday – marking a year in which the chatbot, for many, turned AI from a futuristic concept to a daily reality.
Its universal accessibility has led to a host of concerns, from job losses to disinformation to plagiarism. Over the same period, tens of millions of users have been investigating what the platform can do to make their lives just a little bit easier.
Upon its release, users quickly embraced ChatGPT’s potential for silliness, asking it to play 20 questions or write its own songs. As its first anniversary approaches, people are using it for a huge range of tasks. We’ve all heard about uses like crafting emails, writing student essays and penning cover letters. But with the right prompts, it can take on jobs that are more esoteric but equally useful in everyday life. Here are a few that might come in handy.
Jargon demystifier
You’re at a work meeting, and the accountants are talking about GAAP operating income for Q4 of FY22, the design people are panicked about kerning, and the CEO wants you to circle back to drill down on some pain points. On top of that, your British boss says your work is “quite good” but strangely doesn’t seem happy with it, while your US colleague claims everything anyone has ever done is amazing. Users say they’ve turned to ChatGPT for help as an intermediary, employing it to translate workplace jargon so everyone’s on the same page about the concerns you flagged, tnx.
This isn’t limited to the office: people have used ChatGPT to, for instance, translate a sleep study’s medical terminology, or help craft a legal opinion. It can serve as an intergenerational go-between: users have turned it into a gen Z slang translator (sample sentence from a description of a key historical event: “Titanic, flexing as the unsinkable chonk, sets sail with mad swag, a boatload of peeps, and the vibes of a 1912 rave”).
Pitiless critic
Sometimes you want a real critique of your work, a harsh assessment that your friends and family are too nice to provide. For some, ChatGPT is that critic (though whether the word “real” applies here is debatable). “I use ChatGPT to brutally audit where my copy is falling short of the target audience’s expectations,” a copywriter wrote on Reddit. Some have even found it can give decent (if imperfect) criticism of fiction writing, pointing out redundancies, missing characterization or weak imagery.
There are, of course, ethical questions about the use of ChatGPT in work and school settings. In response, some argue that asking it to be your critic, and learning from its feedback, is a way to improve your writing without letting it put words in your mouth.
It’s not always an easy task: what it gives you depends entirely on how you structure the prompt. Some users find it tough to find the language to “convince” it to be harsh enough. And you’ll get more appropriate feedback if you give it a detailed task – “give me feedback” might not help as much as “I’m writing an essay for college – tell me whether it’s well-structured and clear”.
Robot with feelings
Maybe you don’t want ChatGPT to be mean – maybe you want the opposite. Users have asked ChatGPT for help being nicer in their work emails, especially when they’re secretly fuming. “I write to it: please make me sound like less of an asshole,” said one user.
Sous chef
It’s dinnertime and there’s stuff in the kitchen – but you have no idea what to do with a half-eaten yogurt, a leftover chicken leg, a bag of flour and some forgotten tomatoes on the verge of becoming truly upsetting. Users report that ChatGPT has helped them create impressive meals out of what they have, or come up with ideas based on what’s around and a specified grocery budget. Many users report being pleased with the results, though some recipes sound perhaps too creative: garbanzo bean and cheddar cheese soup, a peanut butter and Nutella quesadilla, and a “carrot and grape salad with muesli crunch” (based on what’s in my own kitchen).
ChatGPT invents an odd recipe. Photograph: ChatGPT/Screenshot
Last month, OpenAI, the tool’s developer, added an image-recognition feature that makes this task even easier – instead of having to list ingredients, users can take photos of the food in their cabinets and ChatGPT will come up with recipes.
Results have been mixed. Beyond the fact that the bot has no taste buds, some users have expressed safety concerns, saying ChatGPT may, for example, convince inexperienced chefs to undercook meat.
Whiteboard interpreter
Following the update allowing ChatGPT to “see”, users have found its interpretation skills to be alarmingly impressive. In a clip making the rounds, an AI developer, Mckay Wrigley, shows it a hand-drawn flowchart on a whiteboard, which it’s able to turn into code that Wrigley runs – and it works. The platform can even tell that the green arrows indicate the steps should be reordered. So you can stop beating yourself up for never having learned to code.
Speedy summarizer
ChatGPT can act as your personal SparkNotes, condensing large quantities of information into small ones – whether that information is in the form of articles, meeting notes or book chapters. Combined with the right browser plugin, it can even summarize entire YouTube videos so you don’t have to listen to an insufferable Ted Talker.
Here is the full link text:
https://www.theguardian.com/technology/2023/oct/12/chatgpt-uses-writing-recipes-one-year
Certainly we are seeing all sorts of ideas on how to use this AI. I, for one, would not have expected how fast we have moved!
David.
This appeared last week:
Fads are a commonly seen manifestation in the health sector.
It could be argued to latest biggie is semaglutide (Ozempic). The drug was introduced as a treatment for Type 2 diabetes but it is the powerful weigh-loss effects that have been noticed in the overweight rich world – which now has a shortage and which has the drug selling in such quantities that it is having a real impact on the Danish GDP! (Yes it is not cheap!)
This is a useful review of what is going on!
October 10, 2023 — 11.22am
Australia’s medicine regulator is investigating several reports of intestinal obstructions in patients using the diabetes turned weight-loss drug Ozempic, in a step that could lead to a change to the drug’s product information.
Ozempic, which has been in short supply since Hollywood stars and influencers boosted its reputation as a quick weight-loss solution, has already been associated with several potential complications, including pancreatitis, diarrhoea, nausea and low blood sugar.
Gary Wittert, an endocrinologist from the University of Adelaide, said these and other possible side effects should serve as a reminder that Ozempic was a medication “intended to treat serious disease”.
“It’s not meant to be thrown around to lose a few kilograms here or there.”
Last month, the US drug regulator, the Food and Drug Administration (FDA), updated Ozempic’s labelling to recognise that cases of a gastrointestinal disorder called ileus have been reported following use of the drug.
Ileus stops the bowel from working normally to move waste out of the body.
Australia’s Therapeutic Good Administration (TGA) confirmed it had also received three reports of intestinal obstructions and one case of “ileus paralytic”, though a spokesman stressed that there may be no link between these events and the medicine.
The TGA is investigating the issue to see if local updates are required to the drug’s product information.
Prescriptions for Ozempic have exploded in recent years in Australia and around the world, in a trend linked to its growing reputation as a fat-burning drug, and off-label prescribing of the medicine designed as a treatment for type 2 diabetes.
A weight-loss version of the drug, called Wegovy, has not yet been made available in Australia.
Wittert said when Ozempic was properly prescribed for type 2 diabetes, it was a life-saving medication for many people. He said it could also be extremely beneficial for patients whose health and quality of life are being harmed by obesity.
“I use it to treat people with diabetes who have got significant obesity and significant obesity-related comorbidities, and it changes their lives completely. And it’s been extremely frustrating, and sometimes distressing for people, to find that they can’t get it… because it’s being used inappropriately,” he said.
Wittert said Ozempic worked on at least three parts of the body. It works on the gut, slowing gastric emptying, which may help explain cases of ileus.
He said it also works on the pancreas and has been linked to rare cases of pancreatitis. Finally, he said it works on the brain to decrease appetite.
Since 2020, 91 cases of pancreatitis following the use of Ozempic, otherwise known as semaglutide, have been reported to the TGA.
“It is important to note that reporting of an adverse event to the TGA or publication in the DAEN does not necessarily mean that a causal link with the medicine is established,” a TGA spokesman said.
Dr Terri-Lynne South, chair of the obesity management group with the Royal Australian College of General Practitioners, said gastrointestinal side effects such as nausea and vomiting were the most common side effects of Ozempic. Other patients reported constipation or diarrhoea, she said.
South said although the class of drugs that Ozempic belongs to had been around for quite a while, they were still learning about the long-term impacts of Ozempic, which was first developed about a decade ago.
A spokesperson for Novo Nordisk, the company behind Ozempic, said patient safety was a top priority for the company and it worked closely with the FDA and TGA “to continuously monitor the safety profile of our medicines”.
More here
With popularity comes all sorts of problems and potential misuse.
Amazingly there are even counterfeit injector pens (it is usually a weekly injection).
https://www.novonordisk-us.com/media/news-archive/news-details.html?id=166119
What with some misuse, counterfeit injectors and really significant side-effects my feeling is this is a drug to be used by experts for patients with diabetes and those at risk of developing it! (which leaves out the Hollywood set etc.)
Having an on-line free for all will end badly and as for it being flogged by on-line drug peddlers as is now happening I reckon regulatory intervention is well overdue. Could give telehealth a very bad name unfairly and do some real harm!
David.
Australia has voted on the Indigenous Voice To Parliament:
Deputy Prime Minister Richard Marles says the government will continue its work on reconciliation and closing the gap despite the defeat of the Voice to parliament referendum.
“Obviously for those of us who are supporting the Yes campaign, it wasn’t the night we hoped for, and I am disappointed, but the Australian people always get it right, and we absolutely accept this result,” he said on ABC’s Insiders this morning.
“But I don’t take last night as any vote against reconciliation, and I think both sides of the argument made that clear, even in their comments after the result last night, nor do I take this as a vote against a will, on the part of the Australian people, to see a closing of the gap in social disadvantage which affects Indigenous Australians.
“To close the gap, and from the government’s point of view, obviously that is now our focus. The Australian people have asked us to do this in a different way. We hear that and we’ll do that and we will now look at how we can work harder.”
Marles said the government had of course weighed up the issues when it became clear the Coalition decided against supporting the Voice, but they always believed it was best to press on.
“Did we understand that it was more difficult? Of course we did. But we didn’t go to the election saying, ‘We will take this to the Australian people so long as Peter Dutton agrees’,” he said.
Here is the link:
In the end it wasn’t even close with the NO vote fining up at close to 60%
It seems clear that despite this overall rejectionist sentiment there are a great number of health related initiatives (including Digital Health development) that need to continue and be further evolved..
The physical and mental health of many of the First Australians is simply unconscionable and an outcome of the failed referendum must surely be to make sure the efforts at consultation with and health support of this population are accelerated and not reduced.
The sad thing is that after a gazillion reports we all know what needs to be done and what resources are required. The time for actual delivery has now arrived, as we put to failed referendum behind us and move forward in a positive way! I wonder will our Governments step up?
David.
Here are the results of the poll.
Yes 4 (15%)
No 21 (78%)
I Have no Idea 2 (7%)
Total No. Of Votes: 27
A clear outcome that I really do not understand! If the prescriber can’t decide on the script duration just who can?
Any insights on the poll are welcome, as a comment, as usual!
A poor number of votes. And also a very clear outcome even if I don’t understand it!
2 of 27 who answered the poll admitted to not being sure about the answer to the question!
Again, many, many thanks to all those very few who voted!
David.
This appeared least week:
This appeared last week:
By Adam Ang
September 29, 2023 04:16 AM
ADHA appoints new board chair
The Australian Digital Health Agency has assigned Lyn McGrath to their board's chair.
McGrath has been a non-executive member of the ADHA Board for over seven years. She has also served as chair of the agency's Audit and Risk Committee.
She will be replacing Dr Elizabeth Deveny, who has been with the organisation since its inception.
"It's with great enthusiasm that I take up the role of Chair of the [ADHA] Board. I look forward to continuing to advance the national digital health agenda and building on the momentum that has already been achieved under Dr Deveny's leadership," McGrath said about her three-year appointment, which begins on 29 September.
Other stories follow here:
https://www.healthcareitnews.com/news/anz/roundup-adha-names-new-board-chair-and-more-briefs
The old chair has been in place since 2016, and the main feature I have noticed in that period is that the ADHA Board is a secret organisation that does not tell anyone outside what it is doing or what its plans other than in the usual glossy puff-pieces we see every year or two.
Pity those affected by its actions (most of us) do not see any minutes etc. of the meetings and are not asked to comment from time to time on how things are going!
Seems to be typical of the way bureaucracy works these days.
Rather sad I reckon.
David.